TRIAL DESIGN AND SETTING
The trial was conducted between April 2017 and February 2019. The institutional review board’s approval (Identification no.: 20153110-(8)14-2017) and participants’ consent were obtained before the treatment.In this split-mouth randomized controlled trial, quadrants were allocated to one of the four experimental groups. The allocation ratio was 1:1:1:1.